| Description |
1 online resource (403 pages) |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Micro and Nano Technologies Ser. |
|
Micro & nano technologies.
|
| Note |
Print version record. |
| Contents |
Front Cover -- Nanoformulation Strategies for Cancer Treatment -- Copyright Page -- Contents -- List of contributors -- A. General consideration on cancer nanomedicines -- 1 Nanomedicine for combinational anticancer drug therapeutics: Recent advances, challenges, and future perspectives -- 1.1 Introduction -- 1.2 Various barriers to overcome in cancer treatment -- 1.3 Combinational anticancer therapeutic approach -- 1.3.1 Polyplexes -- 1.3.2 Liposomes -- 1.3.3 Micelles -- 1.3.4 Dendrimers -- 1.3.5 Host-guest supramolecular chemistry -- 1.3.6 Inorganic systems |
|
1.3.7 Other dual-drug delivery systems -- 1.4 Conclusions and future perspectives -- References -- 2 Market research in cancer therapeutics: New and generic product development -- 2.1 Introduction -- 2.2 Cancer therapeutics -- 2.3 Prevention -- 2.4 Early detection and screening -- 2.5 Diagnosis and treatment -- 2.6 Overall strategies -- 2.7 New and generic product development in the pharmaceutical industry -- 2.8 Developing a plan for marketing and selling specialist therapies -- 2.9 Creating a marketing and sales function that is fit for the future -- 2.10 Conclusions and future perspectives |
|
4 Biopharmaceutical challenges in using lipid nanoparticles for oral chemotherapy -- 4.1 Introduction -- 4.2 Biopharmaceutical chemotherapy obstacles -- 4.3 Lipid nanoparticles for oral cancer chemotherapy -- 4.3.1 Rationale -- 4.3.2 Recent developments -- 4.3.3 Solid lipid nanoparticles -- 4.3.4 Nanostructured lipid carriers -- 4.3.5 Lipid-drug conjugates -- 4.4 Pharmacokinetics of lipid nanoparticles -- 4.4.1 Biodistribution -- 4.4.2 Metabolism and elimination -- 4.5 Future recommendations and conclusion -- References -- Further reading |
|
5 Polymeric nanoparticles for potential drug delivery applications in cancer -- 5.1 Introduction -- 5.2 Rationale to use polymeric nanoparticles in cancer therapy -- 5.3 Advantages of polymeric nanoparticles -- 5.4 Disadvantages of polymeric nanoparticles -- 5.5 Factors considered during the development of nanoformulations -- 5.6 Polymers used for polymeric nanoparticles -- 5.6.1 Natural hydrophilic polymers -- 5.6.2 Synthetic hydrophobic polymer -- 5.7 Mechanisms of nanoparticles uptake by the cancer cells -- 5.7.1 Targeting of polymeric nanoparticles to cancer cells -- 5.7.1.1 Passive targeting |
| Subject |
Nanomedicine.
|
|
Cancer -- Treatment.
|
|
Nanochemistry.
|
|
Nanomedicine |
|
Cancer -- Traitement.
|
|
Nanochimie.
|
|
Nanomédecine.
|
|
Nanomedicine
|
|
Nanochemistry
|
|
Cancer -- Treatment
|
| Added Author |
Beg, Sarwar, 1987-
|
|
Rahman, Mahfoozur.
|
|
Choudhry, Hani.
|
|
Souto, Eliana B.
|
|
Ahmad, Farhan J.
|
| Other Form: |
Print version: Beg, Sarwar. Nanoformulation Strategies for Cancer Treatment. San Diego : Elsevier, ©2020 |
| ISBN |
9780128210963 |
|
0128210966 |
|
9780128210956 |
|
0128210958 |
| Standard No. |
AU@ 000068358381 |
|
AU@ 000068651311 |
|
